
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Wnt-4 CRISPR/Cas9 KO Plasmid (m) | sc-423717 | 20 µg | $397.00 |
Wnt4 encodes the secreted signaling ligand Wnt-4, a key regulator of WNT pathway activity that shapes embryonic development and adult tissue homeostasis. In mouse, Wnt-4 influences cell fate decisions, polarity, migration, and differentiation through context-dependent activation of canonical β-catenin signaling and non-canonical WNT pathways. It is strongly linked to reproductive tract and kidney morphogenesis, osteogenic and stromal programs, and immune microenvironment modulation via downstream transcriptional and cytoskeletal remodeling networks. Dysregulated Wnt-4 signaling has been associated with developmental phenotypes and with disease-relevant processes such as fibrosis, aberrant differentiation, and tumor-associated pathway rewiring used as mechanistic readouts in biomedical research models.
Wnt-4 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Wnt4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Wnt4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Wnt4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Wnt-4 protein expression.
This CRISPR knockout system enables efficient generation of Wnt4-deficient cell models for investigation of Wnt-4 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.